Evidence map›Paper›PMID 33717358›Full record

ArticleJournal of circulating biomarkers

Lung ultrasound and biomarkers in primary care: Partners for a better management of patients with heart failure?

Mar Domingo, Laura Conangla, Josep Lupón, Asunción Wilke, Gladys Juncà, Elena Revuelta-López, Xavier Tejedor, Antoni Bayes-Genis

Open access · goldAbstract read
In one paragraph

Article in Journal of circulating biomarkers. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. New International Guidelines and Consensus on the Use of Lung Ultrasound.Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine · 2023
    Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Mar DomingoHeart Failure Unit and Cardiology Department, Hospital Universitari Germans Trias i Pujol, Badalona - Spain.
Laura ConanglaHeart Failure Unit and Cardiology Department, Hospital Universitari Germans Trias i Pujol, Badalona - Spain.
Josep LupónHeart Failure Unit and Cardiology Department, Hospital Universitari Germans Trias i Pujol, Badalona - Spain.
Asunción WilkePrimary Care Service Barcelonès Nord i Maresme, Catalan Health Institute, Badalona - Spain.
Gladys JuncàHeart Failure Unit and Cardiology Department, Hospital Universitari Germans Trias i Pujol, Badalona - Spain.
Elena Revuelta-LópezHeart Failure Unit and Cardiology Department, Hospital Universitari Germans Trias i Pujol, Badalona - Spain.
Xavier TejedorBiochemistry Service, Hospital Universitari Germans Trias i Pujol, Badalona - Spain.
Antoni Bayes-GenisHeart Failure Unit and Cardiology Department, Hospital Universitari Germans Trias i Pujol, Badalona - Spain.
Hospital Universitari Germans Trias i Pujol · ESInstituto de Salud Carlos III · ESUniversitat Autònoma de Barcelona · ESInstitut Universitari d'Investigació en Atenció Primària Jordi Gol · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe association of pulmonary congestion assessed by lung ultrasound (LUS) and biomarkers-other than N-terminal pro-brain natriuretic peptide (NT-proBNP)-is uncertain.

methodsWe investigated the relationship between total B-line count by LUS and several biomarkers in outpatients with suspicion of heart failure (HF). Primary care patients with suspected new-onset nonacute HF were evaluated both with a 12-scan LUS protocol (8 anterolateral areas plus 4 lower posterior thoracic areas) and 11 inflammatory and cardiovascular biomarkers. A cardiologist blinded to LUS and biomarkers except NT-proBNP confirmed HF diagnosis. After log-transformation of biomarkers' concentrations, unadjusted and adjusted correlations were performed.

resultsA total of 170 patients were included (age 76 ± 10 years, 67.6% women). HF diagnosis was confirmed in 38 (22.4%) patients. After adjustment by age, sex, body mass index, and renal function, total B-line sum significantly correlated with NT-proBNP (R = 0.29, p < 0.001), growth/differentiation factor-15 (GDF-15; R = 0.23, p = 0.003), high-sensitive Troponin T (hsTnT; R = 0.36, p < 0.001), soluble interleukin-1 receptor-like 1 (sST2; R = 0.29, p < 0.001), cancer antigen 125 (CA-125; R = 0.17, p = 0.03), high-sensitivity C-reactive protein (hsCRP; R = 0.20, p = 0.009), and interleukin (IL)-6 (R = 0.23, p = 0.003). In contrast, IL-33 (R = -0.01, p = 0.93), IL-1β (R = -0.10, p = 0.20), soluble neprilysin (sNEP; R = 0.09, p = 0.24), tumor necrosis factor-alpha (TNF-α; R = 0.07, p = 0.39), and TNF-α receptor superfamily member 1A (TNFRSF1A; R = 0.14, p = 0.07) did not.

conclusionsTotal B-line sum correlated significantly, although moderately, with congestion and several inflammation biomarkers. Unexpectedly, the highest correlation found was with hsTnT.

Indexed as

BiomarkersCongestionDiagnosisHeart failureLung ultrasoundPrimary care

Identifiers

PMID33717358
PMCPMC7951183
OpenAlexW3094308723

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.